GeneDx, a fast-growing biotech doing exome and genomic testing, has seen big returns on Wall Street as appetite for its tests ...
Amgen Inc. said as part of its quarterly results that the company has turned down a request from the U.S. FDA that Tavneos (avacopan) be taken off the market. The complement 5a receptor antagonist was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results